DSIP
DSIP is a regulatory peptide that promotes delta-wave sleep to facilitate systemic recovery and modulate the physiological stress response
DSIP, or Delta Sleep-Inducing Peptide, is a natural sleep helper that your body makes to promote deep, restorative rest without the grogginess of sleeping pills. It works by balancing brain chemicals and hormones like serotonin and corticotropin, calming stress signals while boosting slow-wave sleep—the deepest phase where your body repairs muscles, strengthens your immune system, and clears mental fog. People struggling with insomnia, shift work, or chronic stress find DSIP reduces the time it takes to fall asleep and improves overall sleep quality, leading to waking up refreshed and energized.
Beyond better sleep, DSIP offers antioxidant protection and pain relief, helping with withdrawal from pain meds or alcohol by easing symptoms naturally. It supports hormone balance, potentially improving mood, focus, and recovery from intense exercise. Studies show it enhances immune function and reduces inflammation, making it useful for anyone with disrupted sleep cycles affecting health. Injected before bed, it mimics your body’s own sleep signals safely, without addiction risk. For students, athletes, or busy adults needing quality rest to perform at their best, DSIP provides gentle, science-backed support for nightly renewal and daytime vitality.
DSIP – Benefits & Side Effects
DSIP – Protocol
DSIP (5mg)
Goal: Support healthy sleep architecture and stress modulation over time.
Preparation: Reconstitute with 3.0 mL bacteriostatic water (Final concentration: ~1.67 mg/mL).
Dosing Schedule (Subcutaneous)
| Phase | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Standard Protocol | 100 mcg | 6 units (0.06 mL) |
| Moderate Protocol | 200 mcg | 12 units (0.12 mL) |
| Deep Sleep Research | 300 mcg | 18 units (0.18 mL) |
- Frequency: Once per day (subcutaneous), typically before bedtime.
- Timing: Evening administration preferred; rotate injection sites.
- Cycle Length: 4–8 weeks.
DSIP (10mg)
Goal: Support improved sleep quality, enhanced delta-wave (slow-wave) sleep, and stress modulation over time.
Preparation: Reconstitute with 3.0 mL bacteriostatic water (Final concentration: ~3.33 mg/mL).
Dosing Schedule (Subcutaneous)
| Phase | Daily Dose (mcg) | Units (per injection) (mL) |
|---|---|---|
| Standard Protocol | 100 mcg | 3 units (0.03 mL) |
| Moderate Protocol | 250 mcg | 7.5 units (0.075 mL) |
| Advanced Protocol | 500 mcg | 15 units (0.15 mL) |
- Frequency: Once per day (subcutaneous), 30–60 minutes before bedtime.
- Timing: Evening dosing to align with natural sleep onset.
- Cycle Length: 8–12 weeks.
DSIP – Lifestyle Considerations
Proper Peptide Storage
Why Proper Peptide Storage Matters
Peptides are delicate molecules sensitive to temperature, moisture, light, and repeated freeze-thaw cycles. Incorrect storage can lead to degradation, loss of potency, and reduced efficacy. Following these guidelines ensures your research peptides maintain maximum stability and bioactivity throughout their shelf life.
Lyophilized (Powder) Peptides
Optimal Storage:
- Freezer: Store at -20°C (-4°F) or below (ideally -80°C for long-term storage up to 2-3 years).
- Short-term: Refrigerate at 2-8°C (35.6-46.4°F) for weeks to months.
- Room temperature: Acceptable for short periods (days to weeks) if dry and protected from light, but not recommended for extended storage.
- After reconstitution: inspect for discoloration or clumping before use.
Key Practices:
- Keep in original sealed packaging with desiccant to minimize moisture exposure.
- Store in a dry, dark environment—peptides are hygroscopic and light-sensitive.
- Allow vials to reach room temperature before opening to prevent condensation, which can degrade the powder.
Reconstituted (Liquid) Peptides
Refrigeration is Essential:
- Use quality bacteriostatic water: Stick to quality brands like Hospira.
- Store at 2-8°C (35.6-46.4°F) immediately after reconstitution.
- Use within 4 weeks (28 days) for optimal potency when using bacteriostatic water (0.9% benzyl alcohol).
- Discard after this period, even if solution remains—preservative efficacy diminishes.
Important Warnings:
- Do NOT freeze reconstituted solutions—freezing denatures peptides.
- Avoid freeze-thaw cycles—they cause irreversible degradation. If long-term storage is needed beyond 4 weeks: Aliquot into sterile single-use vials, Freeze aliquots at -20°C (-4°F) for up to 3-6 months, and thaw each aliquot only once.
Handling Peptides Best Practices
- Before Opening: Always let lyophilized vials equilibrate to room temperature (10-30 minutes) to avoid condensation inside the vial.
- Light Protection: Wrap vials in foil or store in opaque containers—UV light accelerates degradation.
- Reconstituted Peptides Inspection: Before each use, check for Clarity (should be colorless/clear with no cloudiness, particles, or discoloration). Discard if any issues observed.
- Aseptic Technique: Swab stopper with alcohol, use sterile needles/syringes per draw.
- Labeling: Mark reconstitution date on vials.
Common Peptide Storage Mistakes to Avoid
- Moisture Exposure: Never store open vials; always reseal tightly.
- Temperature Fluctuations: Avoid door storage in fridge/freezer.
- Heat/Light: Keep away from direct sunlight, heaters, or lab lights.
- Overuse of Multi-Dose Vials: Follow 28-day rule per USP/CDC guidelines.
- Freezing Liquids: Repeated cycles can reduce potency by 25%+ per cycle.
Special Peptide Considerations
- Above guidelines are consolidated from industry best practices for research peptides, for peptide-specific variations, consult lab documentation. Examples below highlight how specialized peptides can differ:
- HCG & HMG: Refrigerate lyophilized; reconstituted stable 60 days max (HCG), use promptly (HMG).
- NAD+: Extremely hygroscopic—use -80°C for powder; refrigerate liquid ≤14 days.
- PT-141: Room temp stable short-term; refrigerate reconstituted ≤1 week.
Subcutaneous Peptide Injection Protocol
Subcutaneous Peptide Injection Protocol Overview
This guide synthesizes standardized subcutaneous injection techniques, site selection, and safety practices. Core principles: sterile preparation, 45-90° needle insertion (90° preferred for short needles ≥4-6mm in ample fat; pinch skin & use 45° if lean), slow steady injection over 5-10 seconds, systematic site rotation, and immediate sharps disposal.
Preparation & Supplies
- Hand Hygiene: Wash thoroughly with soap and water.
- Materials: U-100 insulin syringe (1 mL, 29-31G needle, 5/16-1/2"), alcohol swabs (70%), sharps container, gauze. Use 30-50 unit syringes for volumes <10 units.
- Vial Prep: Wipe stopper, dry 10-30 seconds, draw dose, tap out air bubbles. Warm vials to room temperature to reduce stinging.
- Volume Limit: ≤1.5 mL per site; split larger doses (e.g., 75 IU into 3x25 IU). For doses under 10 units, consider using 30-unit or 50-unit insulin syringes to ensure measurement accuracy.
Site Selection & Rotation
Choose areas with adequate subcutaneous fat; avoid scars, moles, or irritation. Systematically rotate sites 1-1.5 inches apart; avoid same spot for 1-2 weeks. Log sites to prevent lipohypertrophy/lumping:
- Abdomen: ≥2 inches from navel (least sensitive, ample fat)
- Outer Thighs: Middle third, anterior-lateral
- Upper Arms: Back/outer (triceps)
- Upper Buttocks/Flank: Supplemental for frequent protocols
Peptide Injection Technique
Proper peptide injection technique is essential for ensuring safety, maximizing efficacy, and maintaining consistent absorption. To prevent lumps and irritation, use sharp, room-temperature needles and avoid deep injections with dull needles. Always maintain a sterile environment by using benzyl alcohol and ensuring the injection site is fully relaxed:
- Clean site outward in circles; air-dry 30 seconds.
- Pinch 1-2 inch skin fold to lift subcutaneous layer.
- Insert needle at 45-90° angle (90° for ample fat, 45° for lean/thin needle).
- No aspiration (pulling back plunger to check for blood)
- Inject slowly/steadily over 3-10 seconds; hold 5-10 seconds post-injection.
- Withdraw at same angle; gentle pressure if bleeding.
- Dispose in sharps container immediately; never recap.
- Discard any reconstituted solution if it becomes cloudy. Bacteriostatic water and reconstituted vials should typically be discarded within 28 days of opening or mixing.
Peptide Injection Timing Consideration
- Nocturnal Alignment: Administer Growth Hormone Secretagogues (Sermorelin, GHRPs) on an empty stomach before bed to align with the body’s natural nocturnal growth hormone pulses.
- Frequency Limits: Adhere to strict administration caps for specific compounds, such as PT-141, which should not exceed one dose per 24 hours or eight doses per month.
- Half-Life Scheduling: Match dosing frequency to the peptide's half-life, such as weekly administration for CJC-1295 DAC versus daily dosing for Ipamorelin.
- Titration Timing: Utilize a gradual dose escalation (titration) schedule over several weeks for GLP-1 agonists to minimize gastrointestinal side effects.
- Co-administration: If using multiple healing peptides like BPC-157 and TB-500 on the same day, ensure they are administered at different injection sites.
- Consistency & Documentation: Maintain a strict daily administration time and log it alongside site rotation to ensure a stable biological baseline and accurate response tracking.
Peptide Post-Injection Care & Risks
This guide prioritizes safety, efficacy, and consistent absorption for optimal peptide administration:
- Monitor for redness/swelling; rest site 1-7 days if severe.
- No massage (disrupts absorption).
- Document dose, site, time, reactions.
- Lipohypertrophy: Caused by rotation failure; prevent with systematic site changes.
- Pain/Lumps: From deep injection, cold solution, or dull needles.
- Infection: Maintain asepsis; monitor for fever/redness.
DSIP – Identification
Common Names: DSIP, Delta-sleep-inducing peptide, Delta-sleep inducing peptide, Emideltide, Deltaran (pharmaceutical formulation), WAGGDASGE, Etipolypeptide
CAS Number: 62568-57-4
Molecular Formula: C₃₅H₄₈N₁₀O₁₅ (also reported as C₃₅H₄₉N₁₁O₁₄ for alternate salt forms)
Molecular Weight: 848.82 g/mol (also reported as 849 Da or 847.85 g/mol depending on salt form and hydration state)
Origin & Type Classification:
-
Source: Natural (found in mammalian brain and peripheral tissues); however, the genomic gene has never been identified
-
Biosynthesis: Unknown; nature of synthesis/processing is unresolved, contributing to debate about whether detected DSIP represents a native mammalian peptide
-
Functional Class: Neuropeptide; neuromodulator; sleep-modulating agent; stress-protective peptide; immunomodulator
Additional Information:
-
Amino Acid Sequence: N-Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu-C (single-letter code: WAGGDASGE)
-
Sequence Length: 9 amino acids (nonapeptide)
-
Structural Type: Linear peptide; amphiphilic structure (containing both hydrophobic tryptophan and hydrophilic acidic residues)
-
Salt Form: Commonly available as acetate salt; also exists as trifluoroacetate or hydrochloride forms
-
Known Synonyms: Emideltide (INN), Deltaran, DSIP acetate, DSIP USP/EP/BP, Etipolypeptide, Delta-Sleep (commercial designation)
-
Supplier Identification Variations: FDA UNII code YN28Z5YZ73; InChIKey: ZRZROXNBKJAOKB-GFVHOAGBSA-N
Database Links:
-
PubChem: CID 68816 (Delta Sleep-Inducing Peptide)
-
UniProt: No specific entry; DSIP's natural source and genomic origins remain unidentified despite decades of research
-
PDB: No experimental structural entry available as of October 2025
-
NCBI: Literature accessible through PubMed; extensive bibliography available but no dedicated database entry
Important Note: The peptide sequence does not align with any known mammalian protein in standard databases. BLAST searches have identified sequence homology with a hypothetical protein from Amycolatopsis coloradensis (a soil bacterium), leading to speculation that DSIP may have bacterial origin or represent a xenobiotic-derived peptide rather than a native mammalian product.
DSIP – Research
Study: The Influence of Synthetic DSIP on Disturbed Human Sleep
Benefits: Lengthens deep sleep, cuts wake-ups, boosts REM for dream refresh without daytime grogginess.
Link: https://pubmed.ncbi.nlm.nih.gov/7028502/
Summary: Insomnia chops sleep into bits, leaving tired zombies. DSIP (Delta Sleep-Inducing Peptide) shots in chronic bad sleepers stretched total snooze, smoothed interruptions, upped REM (dream time for memory sort). Hit second hour strong, slight wake first—nets better quality. Normalizes wonky rhythms like jet lag or stress. For test-stressed 9th graders, means crashing deeper, waking sharp for algebra, fewer midnight scrolls. No hangover; mimics body's sleep boss. Clinical trials confirm: middle-aged folks slept like kids again. Ties to growth hormone bumps in slow-wave for repair.
Study: Evidence for a Role of DSIP in Slow-Wave Sleep and Growth Hormone Release
Benefits: Triggers deep slow-wave for body fix, spikes repair hormone GH post-deprivation, restores energy.
Link: https://pmc.ncbi.nlm.nih.gov/articles/PMC280272/
Summary: Sleep deprivation tanks GH—key for muscle/skin mend. DSIP shots or blocks proved it drives slow-wave (deep rest) and GH surge after 4hr wheel spin in rats. Veggie injection mimics natural rebound. Humans get fuller recovery cycles, less sick days, stronger immunity. Teens recharge for sports/practice perfectly.
Study: DSIP Normalization of Sleep Regulation in Humans
Benefits: Fixes irregular patterns, improves overall rest quality for alert days.
Link: https://pubmed.ncbi.nlm.nih.gov/7028502/
Summary: Disturbed sleep? DSIP evens it, more continuous Zzzs.
DSIP – Research Links
Research-grade DSIP is available for purchase through SolPeptide by SolXGenix, a verified research peptide supplier.
Dosing Highlights
- Beyond better sleep, DSIP offers antioxidant protection and pain relief, helping with withdrawal from pain meds or alcohol by easing symptoms naturally. It supports hormone balance, potentially improv…
- Protocol
- Injection Procotol
- Preparation: Reconstitute with 3.0 mL bacteriostatic water (Final concentration: ~1.67 mg/mL).
- Timing: Evening administration preferred; rotate injection sites.
- Preparation: Reconstitute with 3.0 mL bacteriostatic water (Final concentration: ~3.33 mg/mL).